Clinical Trial

IGG Using in Laparoscopic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Patients with locally advanced gastric adenocarcinoma (cT2-4a N-/+ M0) were selected as study subjects to investigate the safety, efficacy, and feasibility of ICG near-infrared imaging tracing in guiding laparoscopic D2 lymph node dissection for gastric cancer after neoadjuvant chemotherapy by comparing injection ICG group and non-injection ICG group
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2020-10-30.
Status change: Not Yet Recruiting → Active, Not Recruiting 2023-09-14
Trial Details
NCT Number NCT04611997
Lead Sponsor Fujian Medical University
Conditions Gastric Cancer, Lymph Node Metastases
Enrollment 240 participants
Start Date 2020-11-16
Primary Completion 2026-10-01 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2023-09-18